CYP2C19 loss-of-function alleles and the use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel - a real-world study
Event:
ESC Congress 2022
Topic:
Pharmacogenetics
Session:
Short and long-term antiplatelet therapy in clinical practice